PCRX Operating Income Growth
Pacira Biosciences Inc · Operating Income Growth
PCRX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported117.68%period ending
PCRX TTM Operating Income YoY % (-14.94% → 117.68%)
Year-over-year change
High-resolution chart · PNG
PCRX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 117.6788% | |
| 126.8072% | |
| 127.316% | |
| 164.0224% | |
| -212.9877% | |
| -181.3566% | |
| -183.6852% | |
| -245.4857% | |
| 91.6504% | |
| 162.9691% | |
| 46.0666% | |
| -39.8149% | |
| -42.8256% | |
| -55.0068% | |
| -33.2503% | |
| -29.0607% | |
| -7.0687% | |
| 80.4814% | |
| 94.015% | |
| 256.8696% | |
| 544.3229% | |
| 83.7711% | |
| 342.2193% | |
| 39.241% | |
| -37.9015% | |
| 10.7229% | |
| -34.1398% | |
| 73.5639% | |
| 404.0925% | |
| 234.2496% | |
| 163.8143% | |
| 133.7841% | |
| 108.4581% | |
| 59.3222% | |
| 22.1272% | |
| -18.0636% | |
| -1,107.542% | |
| -1,235.2332% | |
| -438.6991% | |
| -267.0112% | |
| -136.3982% | |
| -48.0764% | |
| 283.0591% | |
| 179.4097% | |
| 134.8199% | |
| 116.9336% | |
| 90.3074% | |
| 61.3748% | |
| 44.1502% | |
| 22.7177% | |
| -8.0936% | |
| -23.0606% | |
| -50.899% | |
| -31.7454% | |
| -26.0722% | |
| -60.2674% | |
| -48.3336% | |
| -73.2969% | |
| -74.7698% | |
| -22.6983% | |
| -14.9382% |